Home / Products / Genome-edited Cells / GARRE1 Knockout Hela Polyclonal Cells
GARRE1 Knockout Hela Polyclonal Cells
Datasheet Protocol

GARRE1 Knockout Hela Polyclonal Cells

Cat. No. ARG8017
Product Type:

Polyclonal Cell Population

Species:

Homo sapiens (Human)

Tissue Source:

Uterus (cervix)

Growth Properties:

Adherent

In stock
Request a Quote
Request Quote Ask a Question

Short Description 🔒

GARRE1 Knockout Hela Polyclonal Cells is a knockout polyclonal cell population. The GARRE1 was knocked out in the Hela cells using the CRISPR RNP technique.

Recommended Products

MIR31 Knockout IPEC-J2 Cell Line MIR31 Knockout IPEC-J2 Cell Line Cat. No. ARG43980 PARP12 Knockout HT29 Polyclonal Cells PARP12 Knockout HT29 Polyclonal Cells Cat. No. ARG15014 OSMR Knockout Lovo Polyclonal Cells OSMR Knockout Lovo Polyclonal Cells Cat. No. ARG11705 CNBP Knockout Hela Polyclonal Cells CNBP Knockout Hela Polyclonal Cells Cat. No. ARG7938 HEATR3 Knockout HGC-27 Polyclonal Cells HEATR3 Knockout HGC-27 Polyclonal Cells Cat. No. ARG29913 CLK1 Knockout Raji Polyclonal Cells CLK1 Knockout Raji Polyclonal Cells Cat. No. ARG2028
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Polyclonal Cell Population
Species:
Homo sapiens (Human)
Tissue Source:
Uterus (cervix)
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
31 years
Sex of Donor:
Female
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice
Storage:
Liquid nitrogen (LN2)

Cell Engineering Information

Host Cell:
HeLa
Gene Name:
GARRE1
Gene Identifier:
NCBI Gene ID 9710

Immortalization Information

No immortalization information available.

Culture Conditions

Growth medium:
MEM (with NEAA)
Supplement(s):
10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution
Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

ADGRL1 Knockout Hela Polyclonal Cells

ADGRL1 Knockout Hela Polyclonal Cells

Cat. No. ARG20443
 LRP6 Knockout A549 Polyclonal Cells

LRP6 Knockout A549 Polyclonal Cells

Cat. No. ARG11082
 GLCE Knockout HT29 Polyclonal Cells

GLCE Knockout HT29 Polyclonal Cells

Cat. No. ARG14445
 BRPF3 Knockout HGC-27 Polyclonal Cells

BRPF3 Knockout HGC-27 Polyclonal Cells

Cat. No. ARG29748
 HM13 Knockout HGC-27 Polyclonal Cells

HM13 Knockout HGC-27 Polyclonal Cells

Cat. No. ARG29940
 DAPK2 Knockout HEK293T Polyclonal Cells

DAPK2 Knockout HEK293T Polyclonal Cells

Cat. No. ARG4592